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Abstract
Background: Acute kidney injury (AKI) is a serious complication after cardiac surgery, being associated with
a high mortality. We assessed three urinary biomarkers, L-type fatty acid-binding protein (L-FABP), neutrophil
gelatinase-associated lipocalin (NGAL), and angiotensinogen, which are elevated through different mechanisms,
and investigated which of these biomarkers was the earliest and most useful indicator of AKI after cardiac surgery.
Methods: This study was a prospective observational study conducted at a single-institution university hospital.
All patients were adults aged under 80 years who underwent cardiac surgery with cardiopulmonary bypass between
November 2013 and January 2015. Perioperatively, urine samples were obtained from all patients at five points. Based
on AKI criteria, patients were divided into two groups: AKI group (n = 11) and non-AKI group (n = 39), according
to postoperative serum creatinine (Cr) levels.
Results: Urinary L-FABP, NGAL, angiotensinogen, and Cr were measured perioperatively. L-FABP was significantly
higher in the AKI group than in the non-AKI group at the end of surgery and 3 h after surgery. L-FABP levels
were 601.5 ± 341.7 and 233.8 ± 127.2 μg/g Cr in the AKI and non-AKI groups, respectively. Three hours after
surgery, NGAL levels were 950.5 ± 827.9 and 430.0 ± 250.6 μg/g Cr in the AKI and non-AKI groups, respectively,
the level being significantly higher in the AKI group than in the non-AKI group. There were no significant
differences in urinary angiotensinogen levels between the two groups at any time point.
Conclusions: We demonstrated the utility of L-FABP and NGAL, but not angiotensinogen in the early recognition of
AKI. The problem of the different peak points among biomarkers needs to be resolved for discovery of a
panel of biomarkers.
Keywords: Acute kidney injury, Cardiac surgery, L-type fatty acid-binding protein (L-FABP), Neutrophil
gelatinase-associated lipocalin (NGAL), Urinary angiotensinogen
Background
Acute kidney injury (AKI) is one of the most common
and serious complications after cardiac surgery, being
associated with a high mortality [1]. Depending on the
definition used for AKI, its incidence after cardiac
surgery reportedly ranges from 5 to 30 % [2, 3]. Trad-
itionally, serum creatinine (sCr) has been the main
marker for the diagnosis of AKI. There are three criteria
for the diagnosis of AKI, termed the Risk, Injury, Failure,
Loss of kidney function and End stage of kidney disease
(RIFLE) criteria, Acute Kidney Injury Network (AKIN)
criteria, and Kidney Disease: Improving Global Out-
comes (KDIGO) criteria [4–6]. These criteria include
increasing values and rates of increases of sCr. How-
ever, sCr is not an ideal biomarker for AKI after car-
diac surgery, because it takes 24–48 h after renal
damage for sCr levels to increase, and glomerular fil-
tration rate (GFR) needs to reduce by approximately
75 % before sCr increases to abnormal values [7].
Moreover, previous studies reported that even a small
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increase in sCr (0 to 0.5 mg/dl) is associated with in-
creasing mortality [3]. sCr also has limited sensitivity
and specificity because of several factors such as age,
sex, muscle mass, hypertension, and metabolism that
can affect its value [8]. Further, renal function can be
significantly impaired to an extent that requires renal
replacement therapy despite normal sCr levels [9]. A
previous study reported that sCr might underestimate
the degree of renal failure, especially in elderly pa-
tients [10]. Therefore, the importance of earlier and
more sensitive biomarkers for the diagnosis of AKI
has been recently suggested.
Many urinary and plasma biomarkers for the detection
of AKI have been investigated. AKI induced by different
mechanisms, such as inflammation, reactive oxygen stress,
and intrarenal renin-angiotensin systems, leads to se-
cretion of various biomarkers into urine. In the
present study, we assessed three urinary biomarkers,
L-type fatty acid-binding protein (L-FABP), neutrophil
gelatinase-associated lipocalin (NGAL), and urinary
angiotensinogen, whose urinary concentrations are
elevated through the different mechanisms. The pur-
pose of this study was to investigate which of these
biomarkers is the earliest and most useful indicator of
AKI after cardiac surgery under cardiopulmonary by-
pass (CPB).
Methods
Study design and patient population
This prospective observational study was approved by
the Ethics Committee of Kagoshima University Hospital
and registered with the UMIN Clinical Trials Registry
(UMIN 000012312) on November 18, 2013. The present
study was conducted in accordance with the principles
of the Declaration of Helsinki, and prior written in-
formed consent was obtained from each patient. Fifty
patients undergoing cardiac surgery under CPB were en-
rolled between November 2013 and January 2015. The
exclusion criteria for participants in this study were
emergency operation, low left ventricular function (ejec-
tion fraction <40 %), elderly age (more than 80 years),
and preoperative renal dysfunction (sCr level >1.3 mg/dl),
all of which might directly increase the risk of occurrence
of postoperative AKI.
General management
Patients were prepared according to the standard pre-
operative procedures after overnight fasting. Anesthesia
was induced by injecting 0.08 mg/kg midazolam, 5 μg/kg
fentanyl, and 0.6 mg/kg rocuronium bromide intraven-
ously. Propofol was infused at the rate of 4–10 mg/kg/min
to maintain bispectral index (BIS; Aspect Medical
Systems, Norwood, MA, USA) within the range of
40–60. Remifentanil was also administered as an
infusion, the dose being maintained in the range of
0.1–0.5 μg/kg/min depending on surgical invasiveness.
After the induction of anesthesia, the lungs were ven-
tilated to normocapnia and red blood cells were
transfused to maintain a hematocrit of 25 % or more.
Measurements
Urine samples were obtained at five points (before
surgery (baseline), before and after CPB, at the end of
surgery, and 3 h after surgery). A 5-ml urine sample
was collected at each point and stored at −80 °C for
later measurements of urinary NGAL, L-FABP, angio-
tensinogen, and creatinine. Moreover, sCr was mea-
sured preoperatively and on postoperative days 1, 2,
and 3. Urinary L-FABP, NGAL, and angiotensinogen
levels were determined using specific ELISA kits
(CMIC Co. Ltd, Tokyo, Bioporto Diagnostics, Hellerup,
Denmark, Japan, and IBL, Gunma, Japan, respectively)
and were adjusted for urinary creatinine concentrations.
Definition of AKI
In the present study, we adopted KDIGO criteria to de-
fine AKI, according to which AKI after cardiac surgery is
defined as an increase in sCr of ≥0.3 mg/dl or a percent-
age increase of ≥50 % for 48 h after surgery [6]. Based
on the KDIGO criteria, patients were divided into two
groups: AKI group (n = 11) and non-AKI group (n = 39).
Statistical analysis
Data of patient characteristics and clinical outcomes are
expressed as mean ± standard deviations (SD). Patient
background and outcome variables between the two
groups were compared using Fisher’s exact probability
test or unpaired Student’s t tests using GraphPad Prism
version 5. Data of AKI biomarkers are expressed as me-
dian ± interquartile range (IQR) and were analyzed with
the Wilcoxon test. The performance of urinary bio-
markers was determined using receiver operating char-
acteristic (ROC) curve analysis. We considered P < 0.05
to be statistically significant.
Results
A total of 50 patients were divided into two groups
based on the KDIGO criteria, with 11 subjects in the
AKI group and 39 in the non-AKI group. The patients’
basic and clinical characteristics indicated no significant
differences between the two groups, as seen in Table 1.
Although there were no differences in sCr concentra-
tions before surgery, sCr was higher in the AKI group
than in the non-AKI group at 2 and 3 days after surgery
(Table 2). Our results indicated a significantly greater
need for renal replacement therapy and longer ICU stay
in patients in the AKI group as compared to those in
the non-AKI group (Table 3).
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Urinary L-FABP, NGAL, and angiotensinogen were
measured at five time points perioperatively. Each
marker increased significantly after CPB compared to
baseline levels (before surgery). L-FABP was significantly
higher in the AKI group than in the non-AKI group at
the end of surgery and 3 h after surgery. L-FABP levels
were 601.5 ± 341.7 and 233.8 ± 127.2 μg/g Cr in the AKI
and non-AKI groups, respectively, at the end of surgery
(Fig. 1). Three hours after surgery, NGAL levels were
950.5 ± 827.9 and 430.0 ± 250.6 μg/g Cr in the AKI and
non-AKI groups, respectively, the level being signifi-
cantly higher in the AKI group than in the non-AKI
group for the first time at this point (Fig. 2). In both
groups, urinary angiotensinogen levels were the highest
at the end of surgery, being 945.3 ± 522.7 and 831.0 ±
419.4 μg/g Cr in the AKI and non-AKI groups, respect-
ively. There were no significant differences in urinary
angiotensinogen levels between the two groups at any
time point (Fig. 3).
ROC analysis of urinary L-FABP and NGAL for prediction
of AKI
ROC analysis of L-FABP for the prediction of AKI is
shown in Fig. 4a, while Fig. 4b shows ROC analysis of
NGAL. These results between the AKI and non-AKI
group were analyzed at the most significantly different
time points, which were at the end of surgery for L-
FABP levels and 3 h after surgery for NGAL levels. The
area under the curve (AUC) of NGAL was more than
that of L-FABP, although both NGAL and L-FABP were
found to be significantly positive predictive markers of
AKI. In addition, the cutoff values of L-FABP at the end
of surgery and NGAL at 3 h after surgery for diagnosing
AKI, as analyzed from ROC curves, were 357.5 and
670.5 μg/g Cr, respectively.
Table 1 Patient characteristics
non-AKI group AKI group
(n = 11) (n = 39)
Age (years) 65.2 ± 11.5 63.8 ± 13.1
Sex (male/female) 4/7 16/23
Body weight (kg) 57.5 ± 13.6 55.1 ± 14.3
Diagnosis
Coronary artery disease 2 14
Valvular disease 6 20
Ascending aortic aneurysm 3 5
Operating time (min) 384.1 ± 67.4 361.9 ± 69.1
ACC time (min) 128.1 ± 51.4 119.1 ± 57.4
CPB time (min) 162.7 ± 56.9 157.8 ± 52.5
Intraoprerative urine output (ml) 936 ± 168.6 1053 ± 108.6
Intraoperative fluid balance (min) 1978 ± 335.3 2185 ± 196.1
There were no significant differences between the two groups
ACC aortic closs-clamp, CPB cardio pulmonary bypass
Table 2 Pre- and postoperative serum creatinine (sCr) levels
sCr (mg/dl) AKI group non-AKI group P value
(n = 11) (n = 39)
Preoperative 0.72 ± 0.14 0.68 ± 0.15 0.531
Postoperative
1 day 0.83 ± 0.11 0.69 ± 0.16 <0.05
Postoperative
2 days 1.04 ± 0.15 0.78 ± 0.19 <0.01
Postoperative
3 days 1.05 ± 0.12 0.77 ± 0.18 <0.01
Table 3 Clinical outcomes
AKI group non-AKI group P value
(n = 11) (n = 39)
AKI severity (n)
Stage 1 6 0
Stage 2 3 0
Stage 3 2 0
Need for RRT (n) 3 0 <0.01
ICU stay (day) 8.2 ± 3.5 3.7 ± 2.4 <0.01
ICU death (n) 1 0 0.057
RRT renal replacement therapy, ICU intensive care unit
Fig. 1 Changes in urinary L-FABP from baseline (before surgery) to
3 h after surgery. Urinary L-FABP levels were significantly higher in
the AKI group compared to the non-AKI group at the end of surgery
and 3 h after surgery. *P < 0.05. L-FABP L-type fatty acid-binding
protein, AKI acute kidney injury, CPB cardiopulmonary bypass
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Discussion
Key results
In the present study, of the three biomarkers assessed,
L-FABP increased most rapidly in the AKI as compared
to the non-AKI group. Moreover, there were significant
differences between the AKI and non-AKI group in the
levels of L-FABP and NGAL. NGAL was a more efficient
marker for prediction of the incidence of AKI, because
the AUC-ROC of NGAL 3 h after surgery was higher
than that of L-FABP at the end of surgery.
Issues with sCr and the need for new biomarkers for the
diagnosis of AKI
sCr has been identified as the main index of kidney in-
jury, and the diagnosis of AKI is mainly based on sCr
concentrations in the RIFLE, AKIN, and KDIGO criteria
[4–6]. Recently, several research groups reported that
small increments in sCr after cardiac surgery, which was
not adopted as a diagnostic criterion for AKI, were sig-
nificantly associated with the progression of postopera-
tive AKI and mortality [3, 11–14]. The underlying
mechanism by which a minimal increase in sCr can indi-
cate worsening progression after surgery is not clear.
Further, hemodilution and hydration may lead to falsely
low sCr measurements, which in turn can confound the
diagnosis of AKI after cardiac surgery. This low accuracy
of sCr measurements, in addition to the delay in the in-
crease in sCr after cardiac surgery, is another drawback
of using sCr as a marker of AKI. With the early detec-
tion of AKI, clinical interventions, such as maintaining
adequate renal blood flow and blood pressure, and
avoiding the development of hypovolemia, anemia, and
unnecessary blood transfusion, can be undertaken,
which might contribute to reducing the severity of the
renal damage.
Therefore, a rapid and efficient biomarker is much
needed for the early diagnosis of postoperative AKI.
Until now, there was no ideal and complete biomarker,
although numerous biomarkers have been previously
investigated.
Urinary L-FABP, NGAL, and angiotensinogen
In the present study, we investigated three urinary bio-
markers, L-FABP, NGAL, and angiotensinogen, which
are produced and secreted into urine via different mech-
anisms. L-FABP is a 14-kDa fatty acid-binding protein
and is a biomarker that is secreted in urine as a result of
reactive oxygen stress. The usefulness of L-FABP as a
biomarker in the early detection of AKI after cardiac
surgery has been previously reported [15, 16]. NGAL is
a 25-kDa protein belonging to the lipocalin superfamily,
which is secreted by neutrophils and renal tubular cells
[17]. Urinary NGAL has also been recognized as an early
biomarker of AKI after cardiac surgery [18, 19]. In the
present study, although both urinary NGAL and L-FABP
concentrations increased immediately after CPB in both
the AKI and non-AKI groups, the levels of urinary L-
FABP and NGAL peaked at the end of surgery and
3 h after surgery, respectively. At these time points,
the cutoff values of L-FABP and NGAL for
Fig. 2 Changes in urinary NGAL from baseline (before surgery) to
3 h after surgery. Urinary NGAL levels were significantly higher in the
AKI group compared to the non-AKI group 3 h after surgery. *P < 0.05.
NGAL neutrophil gelatinase-associated lipocalin, AKI acute kidney injury,
CPB cardiopulmonary bypass
Fig. 3 Changes in urinary angiotensinogen from baseline (before
surgery) to 3 h after surgery. There were significant differences
between the AKI group and non-AKI group. Ang angiotensinogen,
AKI acute kidney injury, CPB cardiopulmonary bypass
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diagnosing AKI, as analyzed from ROC curves, were
357.5 and 670.5 μg/g Cr, respectively.
There is a difference between the mechanisms of in-
crease in urinary NGAL and L-FABP after CPB. Oxida-
tive stress via renal tissue hypoxia up-regulates L-FABP
expression and increases the secretion of L-FABP into
urine from damaged proximal tubules [20]. In contrast,
inflammation induced by various stresses increases
serum NGAL, while impaired renal absorption increases
urinary NGAL excretion [21]. Therefore, the increase in
urinary NGAL levels takes a longer time as compared
with urinary L-FABP levels [22]. On the other hand,
urinary angiotensinogen levels were not significantly
different between the two groups at all time points. Re-
cently, the existence of independent renin-angiotensin-
aldosterone systems (RAAS) in several organs and
tissues has been reported. All components of the renal
RAAS are produced in the kidney, being completely in-
dependent of the systemic RAAS, and contribute to the
progression of both acute and chronic kidney diseases
[23]. Moreover, urinary angiotensinogen has been identi-
fied as an index of the activity of the renal RAAS [24],
and a previous study showed that elevated urinary angio-
tensinogen was associated with adverse outcomes after
cardiac surgery in patients with AKI [25]. Therefore,
urinary angiotensinogen has been suggested to have util-
ity as a prognostic biomarker of AKI after cardiac
surgery, similar to other previous biomarkers, including
L-FABP and NGAL. Indeed, urinary angiotensinogen
levels were significantly increased in both the AKI and
non-AKI groups after CPB, as compared to baseline (be-
fore the surgery). Although the intrarenal RAAS is acti-
vated by CPB, the efficacy of urinary angiotensinogen as
a biomarker might not be significant, because the acti-
vated intrarenal RAAS is merely one of many factors
causing AKI after cardiac surgery. Although the useful-
ness of several biomarkers for detecting AKI have been
previously reported [16, 26], in this study, we focused
on comparisons between three biomarkers at the
same time courses that are produced via different
mechanisms. The present results, which confirm the
increase in L-FABP and NGAL levels with AKI, sug-
gest that one of the major mechanisms causing AKI
after cardiopulmonary bypass might be an increase in
reactive oxygen stress, followed by activation of an
intrarenal inflammatory reaction.
Limitations
The present study was conducted at a single institution,
and data analysis was not blinded although surgery and
anesthesia proceeded normally in all cases. Urinary
angiotensinogen concentrations had a wider range as
compared to L-FABP and NGAL, suggesting that the
sample size might have been too small to assess the util-
ity of these biomarkers for the detection of AKI. A panel
of biomarkers would, thus, seem to be more useful for
the early detection of AKI [27], although we could not
demonstrate the advantage of assessing both L-FABP
and NGAL, because the time points at which each of
these biomarkers peaked were different. This might also
be a limitation of our study.
Conclusions
We investigated the efficacy of three biomarkers of AKI
and demonstrated the utility of L-FABP and NGAL, but
not angiotensinogen. All three biomarkers increased
after CPB, although they peaked at different time points
during the observation period. Hence, although evaluat-
ing a panel of biomarkers would probably help overcome
the delay in the diagnosis of AKI after cardiac surgery,
the problem of the different peak points among bio-
markers needs to be resolved for discovery of a panel
of biomarkers.
Fig. 4 a ROC curves for AKI based on uL-FABP levels at the end of surgery. The AUC was 0.8030 (95 % CI 0.68–0.94. ROC receiver operating
characteristic, AUC area under the curve, uL-FABP urinary L-type fatty acid-binding protein, AKI acute kidney injury. b ROC curves for AKI based
on uNGAL levels 3 h after surgery. The AUC was 0.8687 (95 % CI 0.76–0.98). ROC receiver operating characteristic, AUC area under the curve,
uNGAL urinary neutrophil gelatinase-associated lipocalin, AKI acute kidney injury
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